Gerresheimer stock: Shareholder Value values Gerresheimer stock at EUR 48.87

Published on 10/23/2026 at 16:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer regained EcoVadis Gold on October 13, 2026. Gerresheimer stock costs EUR 32.36 on October 23, 2026, up 1.13 percent versus the Xetra close.

Valuation and key dates

Shareholder Value Beteiligungen presented a EUR 48.87 valuation thesis on October 22, 2026.
Gerresheimer received EcoVadis Gold recognition on October 13, 2026.
Gerresheimer stock costs EUR 32.36 at Lang & Schwarz on October 23, 2026 at 4:01 p.m. CEST, 1.13 percent above the Xetra close of October 22, 2026 at EUR 32.00.
Gerresheimer lists a Berenberg European Conference date of December 2, 2026.

Editorialfoto eines Trading-Floors mit MDAX- und Xetra-Kurstafeln — Gerresheimer AG, ISIN DE000A0LD6E6, notiert im MDAX an der Frankfurter Börse Xetra, Trading-Floor-Editorialbild, Illustration mit AI erstellt.

Shareholder Value Beteiligungen valued Gerresheimer stock at EUR 48.87 in a thesis presented on October 22, 2026, according to Latticework. The valuation implies 51.02 percent upside from the EUR 32.36 Lang & Schwarz price. At Lang & Schwarz, the stock was trading at EUR 32.36 on October 23, 2026 at 4:01 p.m. CEST, up 1.13 percent versus the Xetra close of October 22, 2026 at EUR 32.00.

Valuation rests on 9x EBITDA

The thesis by Nils Herzing of Shareholder Value Beteiligungen used a 9x adjusted EBITDA valuation and arrived at EUR 48.87 per share. Latticework also described the remaining company as having an enterprise value of EUR 1.7 billion at the presentation price of EUR 32.70.

Gold rating and price position

Gerresheimer said on October 13, 2026 that it had improved its EcoVadis rating result and received Gold recognition again, according to Gerresheimer. The share price stood 2.77 percent below its 52-week high of EUR 33.28 and 118.14 percent above its 52-week low of EUR 14.83 on October 23, 2026. Trading volume was 30,997 shares.

Dates and peer valuation

Gerresheimer's market capitalization was EUR 1.1 billion on October 23, 2026. The investor calendar lists the Berenberg European Conference for December 2, 2026, while the half-year report is scheduled for November 2026, according to Gerresheimer.

Comparison with peers

Gerresheimer: up 1.13 percent, P/E minus 2.79, market capitalization EUR 1.1 billion.

SCHOTT Pharma (Frankfurt, EUR): down 0.58 percent, P/E 28.02, market capitalization EUR 3.8 billion.

Stevanato Group (Nasdaq, USD): down 0.59 percent, P/E 35.79, market capitalization USD 5.3 billion.

What the valuation means

The key contrast is between the EUR 48.87 valuation thesis and Gerresheimer's negative trailing P/E. The current quote remains 2.77 percent below the 52-week high, placing the valuation debate alongside a clearly defined market level.

Gerresheimer was trading at EUR 32.36 at Lang & Schwarz on October 23, 2026 at 4:01 p.m. CEST, 1.13 percent above the Xetra close of October 22, 2026 at EUR 32.00. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.